Home
Drugs
Carboplatin
Clinical Trials

Clinical Trials Related to Carboplatin

Related studies linked through entity extraction aliases.

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Status: TERMINATED
Phase: PHASE1/PHASE2

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Status: WITHDRAWN
Phase: PHASE1

A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer

Status: TERMINATED
Phase: PHASE2

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Status: UNKNOWN
Phase: PHASE3

Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)

Status: COMPLETED
Phase: PHASE2

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

Status: TERMINATED
Phase: PHASE1

A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients

Status: COMPLETED
Phase: PHASE1

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

Status: COMPLETED
Phase: NA

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Status: COMPLETED
Phase: PHASE2

Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer

Status: COMPLETED
Phase: PHASE2

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Status: COMPLETED
Phase: NA

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

Status: UNKNOWN
Phase: PHASE2

Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Status: TERMINATED
Phase: PHASE3